MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 92 filers reported holding MERUS N V in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,534,057 | -4.3% | 192,284 | +6.8% | 0.00% | 0.0% |
| Q2 2023 | $4,739,295 | +19.8% | 179,996 | -16.3% | 0.00% | 0.0% |
| Q1 2023 | $3,955,043 | +59.5% | 214,948 | +34.1% | 0.00% | +100.0% |
| Q4 2022 | $2,479,624 | +110.5% | 160,286 | +172.6% | 0.00% | 0.0% |
| Q3 2022 | $1,178,000 | -28.5% | 58,804 | -19.2% | 0.00% | 0.0% |
| Q2 2022 | $1,648,000 | -1.6% | 72,813 | +15.0% | 0.00% | 0.0% |
| Q1 2022 | $1,674,000 | -25.2% | 63,319 | -10.0% | 0.00% | 0.0% |
| Q4 2021 | $2,237,000 | – | 70,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 893,527 | $23,625,000 | 21.94% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $42,304,000 | 11.46% |
| COMMODORE CAPITAL LP | 1,816,421 | $48,026,000 | 10.73% |
| MPM BioImpact LLC | 919,482 | $24,311,000 | 6.52% |
| Aquilo Capital Management, LLC | 1,261,534 | $33,355,000 | 4.90% |
| BVF INC/IL | 4,135,071 | $109,331,000 | 4.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 324,719 | $8,586,000 | 3.55% |
| TCG Crossover Management, LLC | 300,000 | $7,932,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 235,500 | $6,227,000 | 2.91% |
| Opaleye Management Inc. | 338,000 | $8,937,000 | 2.78% |